MetaCap

Alignment Healthcare (ALHC) vs Clover Health Investments (CLOV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Clover Health Investments (CLOV) has outperformed Alignment Healthcare (ALHC) over the past year, gaining 63.6% versus a loss of 61.9%. Over five years, CLOV leads with a -31.1% price change compared with -63.3% for ALHC. Clover Health Investments is the larger company by market cap ($2.00 billion vs $1.33 billion), about 1.5 times the size, while Alignment Healthcare is growing revenue faster (+46.1% vs +40.3%).

On valuation, Alignment Healthcare trades at a lower forward P/E (11.5x vs 20.7x for Clover Health Investments). Alignment Healthcare converts more of its revenue into profit, with a net margin of -0.0% versus -4.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ALHC-61.86%CLOV+63.60%
+147%+38%-72%
Nov 21, 20251 yearNov 20, 2026
ALHC-70.71%CLOV-35.13%
+14%-40%-94%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ALHC versus CLOV key metrics
MetricALHCCLOV
Share price$6.37$3.73
Market cap$1.33B$2.00B
1-day change-2.00%-1.06%
YTD return-67.75%+58.72%
1-year return-61.86%+63.60%
5-year return-63.26%-31.05%
P/E ratio (TTM)45.50373.00
Forward P/E11.4820.72
EPS (TTM)$0.14$0.01
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$3.95B$1.92B
Revenue growth (YoY)+46.06%+40.34%
Net income (latest FY)$-724.00K$-85.55M
Operating margin0.37%-4.44%
Net margin-0.02%-4.45%
52-week high$25.12$5.59
52-week low$6.01$1.58
Distance from 52-week high-74.64%-33.27%
Analyst consensusbuybuy
Avg. price target upside+69.39%+50.13%
Average volume8.19M4.49M
Shares outstanding209.27M439.71M
Employees1,849724
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CLOV has outperformed ALHC by 125.5 percentage points over the past year.
  • Clover Health Investments trades at a higher earnings multiple (373.0x vs 45.5x trailing P/E).
  • Alignment Healthcare grew revenue faster in its latest fiscal year (+46.06% vs +40.34%).

About Alignment Healthcare

ALHC stock →

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States.

Health Care · Medical Specialities · 1,849 employees

About Clover Health Investments

CLOV stock →

Clover Health Investments, Corp. provides medicare advantage plans in the United States.

Health Care · Medical Specialities · 724 employees

ALHC vs CLOV FAQ

Which is bigger, Alignment Healthcare or Clover Health Investments?

Clover Health Investments (CLOV) is larger, with a market capitalization of $2.00B compared with $1.33B for Alignment Healthcare (ALHC).

Which stock has performed better over the past year, ALHC or CLOV?

CLOV returned +63.60% over the past 12 months, compared with -61.86% for ALHC (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ALHC or CLOV?

ALHC has the lower trailing P/E at 45.5, versus 373.0 for CLOV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Alignment Healthcare and Clover Health Investments in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons